Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Incidence of Toxic Epidermal Necrolysis in Italy

Incidence of Toxic Epidermal Necrolysis in Italy Abstract To the Editor.— In the January 1990 issue of the Archives, two articles were of great interest to us, both concerning the incidence of toxic epidermal necrolysis.1,2 The study by Roujeau and colleagues was a nationwide surveillance in France covering the period 1981 through 1985. The incidence was estimated from two different sets of data (direct inquiry to dermatologists and mortality data) as 1.2 and 1.3 cases per million per year, respectively. The other study utilized the data system at Group Health Cooperative of Puget Sound, Seattle, Wash, covering about 260 000 people, and considered all hospitilization for toxic epidermal necrolysis, erythema multiforme, and Stevens-Johnson syndrome in that area from 1972 through 1984. The incidence of toxic epidermal necrolysis was estimated at about 0.5 per million per year.In January 1989, we started a case-control surveillance of Stevens-Johnson syndrome and toxic epidermal necrolysis covering 33 dermatological services (hospital and References 1. Roujeau JC, Guillaume JC, Fabre JP, Penso D, Fléchet ML, Girre JP. Toxic epidermal necrolysis (Lyell syndrome) . Arch Dermatol. 1990;126:37-42.Crossref 2. Chan HL, Stern RS, Arndt KA, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis . Arch Dermatol. 1990;126:43-47.Crossref 3. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED). Case-control surveillance of Stevens-Johnson syndrome and Lyell syndrome: presentation of the project of GISED . G Ital Dermatol Venereol. 1990;89:435-440. 4. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED). Lichen planus and liver diseases: a multicentre case-control study . BMJ. 1990;300:227-230.Crossref 5. International Agranulocytosis and Aplastic Anemia Study. Risks of agranulocytosis and aplastic anemia: a first report of their relation to drug use with special reference to analgesics . JAMA. 1986;256:1749-1757.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Dermatology American Medical Association

Incidence of Toxic Epidermal Necrolysis in Italy

Loading next page...
 
/lp/american-medical-association/incidence-of-toxic-epidermal-necrolysis-in-italy-6zO6vr5rlk

References (8)

Publisher
American Medical Association
Copyright
Copyright © 1990 American Medical Association. All Rights Reserved.
ISSN
0003-987X
eISSN
1538-3652
DOI
10.1001/archderm.1990.01670320127028
Publisher site
See Article on Publisher Site

Abstract

Abstract To the Editor.— In the January 1990 issue of the Archives, two articles were of great interest to us, both concerning the incidence of toxic epidermal necrolysis.1,2 The study by Roujeau and colleagues was a nationwide surveillance in France covering the period 1981 through 1985. The incidence was estimated from two different sets of data (direct inquiry to dermatologists and mortality data) as 1.2 and 1.3 cases per million per year, respectively. The other study utilized the data system at Group Health Cooperative of Puget Sound, Seattle, Wash, covering about 260 000 people, and considered all hospitilization for toxic epidermal necrolysis, erythema multiforme, and Stevens-Johnson syndrome in that area from 1972 through 1984. The incidence of toxic epidermal necrolysis was estimated at about 0.5 per million per year.In January 1989, we started a case-control surveillance of Stevens-Johnson syndrome and toxic epidermal necrolysis covering 33 dermatological services (hospital and References 1. Roujeau JC, Guillaume JC, Fabre JP, Penso D, Fléchet ML, Girre JP. Toxic epidermal necrolysis (Lyell syndrome) . Arch Dermatol. 1990;126:37-42.Crossref 2. Chan HL, Stern RS, Arndt KA, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis . Arch Dermatol. 1990;126:43-47.Crossref 3. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED). Case-control surveillance of Stevens-Johnson syndrome and Lyell syndrome: presentation of the project of GISED . G Ital Dermatol Venereol. 1990;89:435-440. 4. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED). Lichen planus and liver diseases: a multicentre case-control study . BMJ. 1990;300:227-230.Crossref 5. International Agranulocytosis and Aplastic Anemia Study. Risks of agranulocytosis and aplastic anemia: a first report of their relation to drug use with special reference to analgesics . JAMA. 1986;256:1749-1757.Crossref

Journal

Archives of DermatologyAmerican Medical Association

Published: Aug 1, 1990

There are no references for this article.